DK3374358T3 - Azetidin-derivater til tau-billeddannelse - Google Patents
Azetidin-derivater til tau-billeddannelse Download PDFInfo
- Publication number
- DK3374358T3 DK3374358T3 DK16798874.0T DK16798874T DK3374358T3 DK 3374358 T3 DK3374358 T3 DK 3374358T3 DK 16798874 T DK16798874 T DK 16798874T DK 3374358 T3 DK3374358 T3 DK 3374358T3
- Authority
- DK
- Denmark
- Prior art keywords
- imagination
- rope
- azetidine derivatives
- azetidine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0444—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562254906P | 2015-11-13 | 2015-11-13 | |
| PCT/US2016/060621 WO2017083198A1 (en) | 2015-11-13 | 2016-11-04 | Azetidine derivatives for tau imaging |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3374358T3 true DK3374358T3 (da) | 2021-03-08 |
Family
ID=57389526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16798874.0T DK3374358T3 (da) | 2015-11-13 | 2016-11-04 | Azetidin-derivater til tau-billeddannelse |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US10301308B2 (da) |
| EP (1) | EP3374358B1 (da) |
| JP (1) | JP2018531978A (da) |
| KR (1) | KR20180061364A (da) |
| CN (1) | CN108290883B (da) |
| AU (1) | AU2016351609B2 (da) |
| BR (1) | BR112018006969B1 (da) |
| CA (1) | CA3003884C (da) |
| DK (1) | DK3374358T3 (da) |
| EA (1) | EA034018B1 (da) |
| ES (1) | ES2864825T3 (da) |
| HK (1) | HK1257042A1 (da) |
| IL (1) | IL258313B (da) |
| MX (1) | MX2018005376A (da) |
| PL (1) | PL3374358T3 (da) |
| PT (1) | PT3374358T (da) |
| SA (1) | SA518391527B1 (da) |
| WO (1) | WO2017083198A1 (da) |
| ZA (1) | ZA201802526B (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023150483A1 (en) * | 2022-02-03 | 2023-08-10 | Eli Lilly And Company | Regional tau imaging for diagnosing and treating alzheimer's disease |
| WO2024163546A1 (en) * | 2023-02-02 | 2024-08-08 | Eli Lilly And Company | Novel compounds for tau imaging |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2004054978A1 (ja) * | 2002-12-16 | 2006-04-20 | 株式会社 ビーエフ研究所 | タウ蛋白蓄積性疾患の診断プローブとしてのキノリン誘導体 |
| FI2247558T4 (fi) | 2008-02-14 | 2024-09-19 | Eli Lilly And Company | Uusia kuvantamisaineita neurologisen toimintahäiriön toteamiseen |
| NZ593848A (en) * | 2008-12-31 | 2013-09-27 | Avid Radiopharmaceuticals Inc | Synthesis of 18f-radiolabeled styrylpyridines from tosylate precursors and stable pharmaceutical compositions thereof |
| US8691187B2 (en) * | 2009-03-23 | 2014-04-08 | Eli Lilly And Company | Imaging agents for detecting neurological disorders |
| ES2792830T3 (es) | 2012-05-22 | 2020-11-12 | Lilly Co Eli | Agentes para formación de imagen en base a carbolina y carbazol, para la detección de disfunción neurológica |
-
2016
- 2016-11-04 WO PCT/US2016/060621 patent/WO2017083198A1/en active Application Filing
- 2016-11-04 MX MX2018005376A patent/MX2018005376A/es unknown
- 2016-11-04 JP JP2018522120A patent/JP2018531978A/ja not_active Withdrawn
- 2016-11-04 CA CA3003884A patent/CA3003884C/en active Active
- 2016-11-04 PL PL16798874T patent/PL3374358T3/pl unknown
- 2016-11-04 KR KR1020187013117A patent/KR20180061364A/ko not_active Application Discontinuation
- 2016-11-04 EA EA201890799A patent/EA034018B1/ru not_active IP Right Cessation
- 2016-11-04 DK DK16798874.0T patent/DK3374358T3/da active
- 2016-11-04 PT PT167988740T patent/PT3374358T/pt unknown
- 2016-11-04 US US15/763,608 patent/US10301308B2/en active Active
- 2016-11-04 BR BR112018006969-8A patent/BR112018006969B1/pt active IP Right Grant
- 2016-11-04 ES ES16798874T patent/ES2864825T3/es active Active
- 2016-11-04 CN CN201680066210.8A patent/CN108290883B/zh active Active
- 2016-11-04 AU AU2016351609A patent/AU2016351609B2/en active Active
- 2016-11-04 EP EP16798874.0A patent/EP3374358B1/en active Active
-
2018
- 2018-03-22 IL IL258313A patent/IL258313B/en active IP Right Grant
- 2018-04-17 ZA ZA201802526A patent/ZA201802526B/en unknown
- 2018-05-07 SA SA518391527A patent/SA518391527B1/ar unknown
- 2018-12-18 HK HK18116177.1A patent/HK1257042A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017083198A1 (en) | 2017-05-18 |
| US10301308B2 (en) | 2019-05-28 |
| BR112018006969A2 (pt) | 2018-10-16 |
| SA518391527B1 (ar) | 2021-02-07 |
| BR112018006969B1 (pt) | 2022-04-26 |
| EA034018B1 (ru) | 2019-12-19 |
| EA201890799A1 (ru) | 2018-10-31 |
| PL3374358T3 (pl) | 2021-07-12 |
| CN108290883B (zh) | 2021-02-09 |
| US20180282322A1 (en) | 2018-10-04 |
| CA3003884A1 (en) | 2017-05-18 |
| IL258313A (en) | 2018-05-31 |
| PT3374358T (pt) | 2021-03-31 |
| ZA201802526B (en) | 2019-10-30 |
| EP3374358B1 (en) | 2021-02-17 |
| CA3003884C (en) | 2020-04-21 |
| AU2016351609B2 (en) | 2019-08-08 |
| CN108290883A (zh) | 2018-07-17 |
| MX2018005376A (es) | 2018-08-01 |
| IL258313B (en) | 2021-04-29 |
| AU2016351609A1 (en) | 2018-04-19 |
| JP2018531978A (ja) | 2018-11-01 |
| KR20180061364A (ko) | 2018-06-07 |
| HK1257042A1 (zh) | 2019-10-11 |
| EP3374358A1 (en) | 2018-09-19 |
| ES2864825T3 (es) | 2021-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FIC20230006I1 (fi) | Vutrisiraani | |
| HK1253304A1 (zh) | 苯氧基甲基衍生物 | |
| DK3283625T3 (da) | Nukleasemedieret genomeditering | |
| DK3319956T3 (da) | Substituerede oxopyridinderivater | |
| DK3277719T3 (da) | Polypeptider | |
| DK3270930T3 (da) | Præeklampsi | |
| DK3231803T3 (da) | Dihydroindolizinonderivat | |
| DK3131898T3 (da) | Fluoroalkylfluorenderivativer | |
| DK3394281T3 (da) | Gærcelle | |
| DK3597189T3 (da) | Krystallinske forbindelser | |
| DE112015006486A5 (de) | Inkubationsrinne | |
| DK3274482T3 (da) | Stenborsknop | |
| DE112015005906A5 (de) | Gurtschlossbringer | |
| DE112016005599A5 (de) | Strahlungsgrill | |
| DK3371163T3 (da) | Pyrrolidinderivater | |
| DE102015206660A8 (de) | Plattenaufteilanlage | |
| DK3374358T3 (da) | Azetidin-derivater til tau-billeddannelse | |
| DK3286193T3 (da) | Indolderivater | |
| DE112016002427A5 (de) | Hebezeug | |
| DE112016001124A5 (de) | Spannschutz | |
| DE102015000551A8 (de) | Rotationszerstäuberturbine | |
| DE102015226549B8 (de) | Hybridheizmodul | |
| UA31512S (uk) | Сірник | |
| UA31513S (uk) | Сірник | |
| UA32865S (uk) | Драбина |